Showing results (101-110 of 286) with videos related to
Sort By:
Pageof 29
American Journal of Clinical Oncology|June 1, 1991
Phase II trial of cisplatin, adriamycin, and etoposide for metastatic endometrial adenocarcinomaM S Piver, J Fanning, T R BakerObstetrics and Gynecology|September 1, 1980
Melphalan, 5-fluorouracil, and medroxyprogesterone acetate in metastatic or recurrent endometrial carcinoma. Preliminary reportM S Piver, S Lele, J J BarlowGynecologic Oncology|March 1, 1987
Plasminogen activator content of gynecological tumors and their metastasesS M Camiolo, G Markus, M S PiverEuropean Journal of Gynaecological Oncology|January 1, 1988
Malignant peritoneal cytology in stage I endometrial adenocarcinoma: the effect of progesterone therapy (a preliminary report)M S Piver, S B Lele, M GamarraGynecologic Oncology|May 1, 1988
Comparison of serum CA-125 and lipid-associated sialic acid (LASA-P) in monitoring patients with invasive ovarian adenocarcinomaB Patsner, W J Mann, M Vissicchio, et al.Gynecologic Oncology|May 1, 1989
Management of lymphocysts after radical gynecologic surgeryW J Mann, F Vogel, B Patsner, et al.American Journal of Clinical Oncology|February 1, 1987
Cisplatin plus VP16-213 in refractory ovarian carcinomaS B Lele, M S Piver, J MalfetanoJournal of Surgical Oncology|June 1, 1987
Hydroxyurea plus pelvic radiation versus placebo plus pelvic radiation in surgically staged stage IIIB cervical cancerM S Piver, V Vongtama, L J EmrichObstetrics and Gynecology|March 1, 1984
Adenocarcinoma in an isolated sigmoid urinary conduitD L Marchetti, M S Piver, Y TsukadaCancer Treatment Reports|January 1, 1981
Cyclophosphamide, hexamethylmelamine, doxorubicin, and cisplatin (CHAD) as second-line chemotherapy for ovarian adenocarcinomaM S Piver, S Lele, J J BarlowPageof 29